More Commercial Articles


Building a commercial dream team for today’s pharma industry

Brian Eastwood, (Dec 7, 2022)

The transformation in the way pharma and HCPs interact is leading pharma companies to reorganize and rethink the makeup and approach of its commercialization teams 

Omnichannel: How will pharma get there?

Brian Eastwood, (Nov 8, 2022)

The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management

Becoming agile in experience measurement 

Andrew Stone, (Sep 13, 2022)

The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble

Paving the payment path for DTx 

Andrew Stone, (Jun 28, 2022)

The digital therapeutics reimbursement process is maturing but complexity and risk remain to be managed

The field force: Is small beautiful?

Andrew Stone, (May 5, 2022)

As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more with less?

Cell & Gene Therapy: High stakes and high hopes for healthcare   

Pamela Whitby, (Mar 29, 2022)

Now that CGT is proving its worth, the next task for pharma is working out the best ways to commercialise it

Unlocking the full potential of biosimilars

Pamela Whitby, (Jul 2, 2021)

The future looks bright for biosimilars in an age of crisis over healthcare affordability

Accelerating commercial success in CAGT

Dean Griffiths, (Mar 22, 2021)

To build on the successes thus far in cell and gene therapy, pharma must foster further payer, physician and patient buy-in

Blended and augmented: Reimagining the role of the rep

Andrew Stone, (Dec 18, 2020)

The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement

Uncorking the compliance bottlenecks in digital

Andrew Stone, (Dec 17, 2020)

The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology